Application 207233
- Type
- NDA
- Sponsor
- ZYLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VIVLODEX | MELOXICAM | CAPSULE;ORAL | 5MG | Yes | No |
| 002 | VIVLODEX | MELOXICAM | CAPSULE;ORAL | 10MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N207233-001 | VIVLODEX | MELOXICAM | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | |
| N207233-002 | VIVLODEX | MELOXICAM | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N207233-001 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | |
| N207233-001 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | |
| N207233-001 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | |
| N207233-001 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | |
| N207233-002 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | |
| N207233-002 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | |
| N207233-002 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | |
| N207233-002 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207233-001 | VIVLODEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207233-002 | VIVLODEX | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE / ORAL | RLD | 2015-10-22 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N207233-001 | VIVLODEX | 5MG | CAPSULE / ORAL | RLD | 2015-10-22 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N207233-002 | VIVLODEX | 10MG | CAPSULE / ORAL | RLD | 2015-10-22 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N207233-001 | VIVLODEX | 5MG | CAPSULE / ORAL | RLD | 2015-10-22 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N207233-002 | VIVLODEX | 10MG | CAPSULE / ORAL | RLD | 2015-10-22 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N207233-001 | VIVLODEX | 5MG | CAPSULE / ORAL | RLD | 2015-10-22 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N207233-002 | VIVLODEX | 10MG | CAPSULE / ORAL | RLD, RS | 2015-10-22 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2020-11-12 02:37 UTC | 2020-11 | N207233-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N207233-002 | AB | 1 | c0c555d07b60… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N207233-001 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207233-001 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207233-001 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207233-001 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207233-002 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207233-002 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207233-002 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207233-002 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-001 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-001 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-001 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-001 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-002 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-002 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-002 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207233-002 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-001 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-001 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-001 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-001 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-002 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-002 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-002 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207233-002 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-001 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-001 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-001 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-001 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-002 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-002 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-002 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207233-002 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-001 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-001 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-001 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-001 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-002 | 9526734 | 2033-03-31 | Drug product | 2016-12-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-002 | 9649318 | 2035-03-31 | Drug product | 2017-05-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-002 | 9808468 | 2035-03-31 | U-2160 | 2017-11-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207233-002 | 9808468 | 2035-03-31 | U-2165 | 2017-11-22 | 6a471c1ec25d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MELOXICAM | MELOXICAM | Redpharm Drug | 5407aded-9f84-72ce-e063-6394a90ae672 | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| MELOXICAM | MELOXICAM | St. Mary's Medical Park Pharmacy | fbe71312-0f9d-47c1-e053-6394a90a63a1 | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| meloxicam | MELOXICAM | St. Mary's Medical Park Pharmacy | 60c954d5-bd5a-33f9-e053-2a91aa0ab597 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| Meloxicam | MELOXICAM | Emerald Therapeutics, LLC | 55af77dd-2abc-49a6-990c-399d5a5e7a91 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| Meloxicam | MELOXICAM | Avondale Pharmaceuticals, LLC | 4ddf5a4d-8e84-419d-8e3a-c91b85501885 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| meloxicam | MELOXICAM | St. Mary's Medical Park Pharmacy | 60c9ab35-4b6e-383d-e053-2a91aa0a26ad | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| meloxicam | MELOXICAM | Coupler LLC | 52bd9bcd-4902-f9dd-e063-6294a90a604e | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| meloxicam | MELOXICAM | REMEDYREPACK INC. | fabd063a-d3a5-44a3-90a2-e33d721b7a95 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| meloxicam | MELOXICAM | Proficient Rx LP | 459bd9c0-1102-46d3-8020-5fec80d1ec36 | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| Meloxicam | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | 1ab45be4-b2b9-4374-95ab-620e0f90fb70 | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| Meloxicam | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | eae60d2c-411c-460a-b673-05b5784ed943 | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| meloxicam | MELOXICAM | Coupler LLC | 5071e1fd-5321-42cf-e063-6294a90a0ef6 | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| MELOXICAM | MELOXICAM | Medcore LLC | 1160b6a8-d507-40b6-925b-25bf186daa30 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| meloxicam | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | 1d8b617a-b9b3-473c-be9b-f34a585a1b3b | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| MELOXICAM | MELOXICAM | Direct Rx | c172a767-eb26-4995-b2a2-f3c5e87b4943 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | af9ce58c-3cd7-769f-e053-2a95a90a5385 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| Meloxicam | MELOXICAM | Golden State Medical Supply, Inc. | d27feaf7-731e-1a8f-e053-2a95a90afa71 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| MELOXICAM | MELOXICAM | A-S Medication Solutions | fe41eca5-33f1-4ded-a177-d8f927f3f261 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| MELOXICAM | MELOXICAM | A-S Medication Solutions | 2cc0c4c2-eac9-4820-942a-6c606dfb4aa1 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
| MELOXICAM | MELOXICAM | A-S Medication Solutions | 7a4212a8-7761-4a77-aa18-ecf1f1244df2 | 2026-02-08 | Boxed warning, Warnings, Adverse reactions | MELOXICAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42211-205 | Vivlodex | meloxicam | Iroko Pharmaceuticals, LL | NDA | Current |
| 42211-205 | Vivlodex | meloxicam | Iroko Pharmaceuticals, LLC | NDA | Current |
| 42211-206 | Vivlodex | meloxicam | Iroko Pharmaceuticals, LL | NDA | Current |
| 42211-206 | Vivlodex | meloxicam | Iroko Pharmaceuticals, LLC | NDA | Current |
| 69344-205 | Vivlodex | meloxicam | Egalet US Inc. | NDA | Current |
| 69344-205 | Vivlodex | meloxicam | Egalet US Inc. | NDA | Current |
| 69344-205 | Vivlodex | meloxicam | Egalet US Inc. | NDA | Current |
| 69344-206 | Vivlodex | meloxicam | Egalet US Inc. | NDA | Current |
| 69344-206 | Vivlodex | meloxicam | Egalet US Inc. | NDA | Current |
| 69344-206 | Vivlodex | meloxicam | Egalet US Inc. | NDA | Current |